會員登入
註冊
2024 Regenerative Medicine Summit: Advancing iPSC Technology
- 日 期：2024-12-06
- 地 點：台北南港展覽館1館4樓 404會議室
- 主辦單位： 義大醫療財團法人義大醫院、昱星生物科技股份有限公司、國立成功大學醫學院
- 活動網址
活動介紹
2024 Regenerative Medicine Summit: Advancing iPSC Technology
我們誠摯地邀請您參加 2024 台灣醫療科技展，展期第二天的重磅論壇活動：「2024 再生醫療論壇－iPSC 誘導性多能幹細胞技術前沿」。本活動將於 2024 年 12 月 6 日下午在台北南港展覽館一館 (TaiNEX) 404會議室隆重舉行。
今年的論壇，我們榮幸地邀請到來自美國、日本及台灣的醫療、學術及產業界的頂尖專家，共同探討誘導性多功能幹細胞 (iPSC) 的的最新發展及未來方向。論壇主題將涵蓋最先進的研究成果、醫學應用、自動化及產業策略。我們期待與各位業界先進深入交流，共同探討最新的技術趨勢及潛在合作機會。誠摯歡迎您的蒞臨，並期待您寶貴的見解。
We sincerely invite you to attend a key summit on the second day of the 2024 Taiwan Healthcare+ Expo: the "2024 Regenerative Medicine Summit: Advancing iPSC Technology." This event will take place on the afternoon of December 6, 2024, at the Taipei Nangang Exhibition Center (TaiNEX).
This year, we are honored to welcome leading experts from the United States, Japan, and Taiwan across the medical, academic, and industrial sectors to discuss the latest developments and future directions of induced pluripotent stem cell (iPSC) technology. Topics will range from the most advanced research to medical applications, automation, and industry strategies. We look forward to in-depth discussions with esteemed professionals like you on emerging technology trends and potential collaboration opportunities. Your presence and valuable insights would be most welcome.
活動日期及時間：2024年12月6日 下午1點開始
活動地點：台北南港展覽館1館4樓 404會議室
主辦單位: 義大醫療財團法人義大醫院、昱星生物科技股份有限公司、國立成功大學醫學院
協辦單位: 惠揚生技股份有限公司
活動議程
| Time | Topic | Speaker | Moderator |
| 13:00-13:30 | Registration | ||
| 13:30-13:40 | Opening Remarks | Deputy Minister, E-Da Healthcare Group Executive Committee Prof. Ker, Chen-Guo, M.D., Ph.D. |
|
| 13:40-14:15 | iPSC therapeutic strategy light up the way for cures | CEO, LumiSTAR Biotechnology, Inc. Yu-Fen Chang, Ph.D. | Vice superintendent, Department of Hematology/Oncology, E-Da Cancer Hospital Prof. Kun-Ming Rau, M.D., Ph.D. |
| 14:15-14:50 | Application of iPSC technologies for diseases modeling and therapeutic development | Research Fellow/Professor, Genomics Research Center, Academia Sinica Prof. Chia-Ning Shen, Ph.D. |
CEO, LumiSTAR Biotechnology, Inc. Yu-Fen Chang, Ph.D. |
| 14:50-15:25 | QbD-based iPSC Automation Expansion Systems and CDMO Strategy in Taiwan | Project Professor, Kobe University, Graduate School of Science, Technology and Innovation/ CEO, Cyto-Facto Inc. Prof. Shin Kawamata, M.D., Ph.D. |
|
| 15:25-15:40 | Break Time | ||
| 15:40-16:15 | Introduction to Allele's iPSC Technology and Global Expansion Strategy | CEO, Allele Biotechnology & Pharmaceuticals, Inc Jiwu Wang, Ph.D. |
Vice superintendent, Department of Hematology/Oncology, E-Da Cancer Hospital Prof. Kun-Ming Rau, M.D., Ph.D. |
| 16:15-16:50 | Research on the Application of iPSC-Derived Exosomes in Neural and Cartilage Repair | Superintendent, E-DA Hospital. Prof. Yuan-Kun Tu, M.D., Ph.D. |
|
| 16:50-17:25 | Development of iPSC Technology for Multi-Tissue Repair Applications | College of Medicine, NCKU Prof. Yan-Shen Shan, M.D., Ph.D. |
|
| 17:25-17:35 | Discussion | ||
| 17:35-17:45 | Closing Remarks | CEO, LumiSTAR Biotechnology, Inc. Yu-Fen Chang, Ph.D. | |
